1. Olympus Corporation issued a Class I recall for its high-flow insufflation unit UHI-4 used to facilitate laparoscopic and endoscopic observation, diagnosis and treatment.
2. The FDA warned consumers to stop using 26 over-the-counter artificial tear products as they may pose a risk of infection leading to potential blindness.
3. Cardinal Health is notifying customers of incompatibility between syringe pumps and more than 20 million of its Luer-Lock Tip Soft Pack syringes.
4. Fresenius Medical Care issued a Class I recall for more than 374,000 syringes distributed across the U.S.
5. Smiths Medical, an entity of ICU Medical, is recalling more than 108,000 syringe pumps because a false alarm may sound.
6. Hospira, a New York City-based Pfizer company, recalled two lots of lidocaine and one lot of sodium bicarbonate because vials could contain glass particles.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
